benzimidazole has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, A; Darge, K; Kern, P; Kratzer, W; Manfras, B; Reske, SN; Reuter, S; Seitz, HM | 1 |
| Ammann, RW; Clavien, PA; Deplazes, P; Grimm, F; Kadry, Z; Kuenzle, AK; Muellhaupt, B; Renner, EL; Renner-Schneiter, EC; Stumpe, KD; von Schulthess, GK | 1 |
1 trial(s) available for benzimidazole and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Structured treatment interruption in patients with alveolar echinococcosis.
Topics: Adult; Aged; Aged, 80 and over; Anthelmintics; Benzimidazoles; Echinococcosis, Pulmonary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Alveoli; Recurrence; Tomography, Emission-Computed | 2004 |
1 other study(ies) available for benzimidazole and fluorodeoxyglucose f18
| Article | Year |
|---|---|
F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
Topics: Adult; Aged; Animals; Anthelmintics; Benzimidazoles; Diagnosis, Differential; Echinococcosis, Hepatic; Echinococcus multilocularis; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |